Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

ViroSpot microneutralization assay for antigenic characterization of human influenza viruses.

van Baalen CA, Jeeninga RE, Penders GH, van Gent B, van Beek R, Koopmans MP, Rimmelzwaan GF.

Vaccine. 2017 Jan 3;35(1):46-52. doi: 10.1016/j.vaccine.2016.11.060. Epub 2016 Nov 26.

2.

Association Between Intermittent Hypoxemia or Bradycardia and Late Death or Disability in Extremely Preterm Infants.

Poets CF, Roberts RS, Schmidt B, Whyte RK, Asztalos EV, Bader D, Bairam A, Moddemann D, Peliowski A, Rabi Y, Solimano A, Nelson H; Canadian Oxygen Trial Investigators..

JAMA. 2015 Aug 11;314(6):595-603. doi: 10.1001/jama.2015.8841.

PMID:
26262797
3.

Impact of study oximeter masking algorithm on titration of oxygen therapy in the Canadian oxygen trial.

Schmidt B, Roberts RS, Whyte RK, Asztalos EV, Poets C, Rabi Y, Solimano A, Nelson H; Canadian Oxygen Trial Group..

J Pediatr. 2014 Oct;165(4):666-71.e2. doi: 10.1016/j.jpeds.2014.05.028. Epub 2014 Jun 25.

PMID:
24973289
4.

A trial comparing noninvasive ventilation strategies in preterm infants.

Kirpalani H, Millar D, Lemyre B, Yoder BA, Chiu A, Roberts RS; NIPPV Study Group..

N Engl J Med. 2013 Aug 15;369(7):611-20. doi: 10.1056/NEJMoa1214533.

5.

Effects of targeting higher vs lower arterial oxygen saturations on death or disability in extremely preterm infants: a randomized clinical trial.

Schmidt B, Whyte RK, Asztalos EV, Moddemann D, Poets C, Rabi Y, Solimano A, Roberts RS; Canadian Oxygen Trial (COT) Group..

JAMA. 2013 May 22;309(20):2111-20. doi: 10.1001/jama.2013.5555.

PMID:
23644995

Supplemental Content

Loading ...
Support Center